Japanese study tracks Real-World use of eye injection for blurry vision
NCT ID NCT06929143
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study looks at how aflibercept 8 mg, a drug injected into the eye, is used in routine care for people with age-related macular degeneration or diabetic macular edema in Japan. Researchers will analyze existing health records from about 3000 patients to understand who gets the treatment and how often. No new tests or visits are needed—only data already collected from regular doctor visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bayer
Osaka, 5300001, Japan
Conditions
Explore the condition pages connected to this study.